-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Atossa Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Atossa Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$6.05M, a 38.5% increase year-over-year.
- Atossa Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$25.9M, a 18% increase year-over-year.
- Atossa Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$30.1M, a 11.6% decline from 2022.
- Atossa Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$27M, a 30.8% decline from 2021.
- Atossa Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$20.6M, a 15.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)